Latest multiple sclerosis Stories
-- Expanded Data from Phase II MS Trial to be Released Next Month; Plans on Course to Advance C. difficile and C-IBS Programs into the Clinic During 2014 -- ROCKVILLE, Md., Aug.
COPENHAGEN, Denmark, Aug.
Biogen Idec's Tecfidera is Forecast to Overtake Teva's Copaxone Franchise as the U.S. Market Leader by 2015, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug.
-- Oral Presentation to Include Greater Detail on Clinical Outcomes, Including Significant and Unique Improvements in Cognition -- ROCKVILLE, Md., July 31, 2014 /PRNewswire/ -- Synthetic
DailyGossip.org reveals in its latest review that a new program, the Natural Multiple Sclerosis Treatment, has been developed for sufferers to access a natural, safe way of stopping multiple sclerosis.
MarketOptimizer.org adds “Multiple Sclerosis Global Clinical Trials Review, H2, 2014” to its store.
Net Sales $279 Million; Increase of 42% over Prior Year Non-GAAP Results ANAHEIM, Calif., July 24, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.
Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass.,
- Largest Global Scientific, Research and Medical Gathering of Professionals Advancing Research and Treatment in Multiple Sclerosis - BOSTON, July 17, 2014 /PRNewswire/ -- The upcoming 2014
Every Month Hands-On Physical Therapy Raises Money for an Important Cause: This Month Was the Fight Against Multiple Sclerosis Astoria, New York (PRWEB) July
- a meat pie that is usually eaten at Christmas in Quebec
More Images (1 images) »